Difference in effective dosage of genistein on bone and uterus in ovariectomized mice.
Phytoestrogen including soybean isoflavones has structural similarity to estrogen and exhibits beneficial effects on bone tissue to protect against bone loss under estrogen-deficient conditions. Recent studies also indicate a possible action of isoflavones as endocrine disrupters in reproductive tissues. In this study, we administered various dosages of genistein to ovariectomized (OVX) mice, and compared the effective dosages of genistein on bone and uterus. Treatment with genistein at 0.7 mg/day prevented trabecular bone loss in OVX mice without hypertrophic effects on the uterus, while administration of 5 mg/day of genistein induced uterine hypertrophy. The serum levels of genistein in OVX mice treated with 0.7 mg/day and 5 mg/day were 3-fold (1.3 nmol/ml) and 50-fold (20.4 nmol/ml) higher than that in OVX mice. These results suggest that there is a marked difference between genistein dosages that protect against bone loss and those that induce uterine hypertrophy.
Division of Food Science, National Institute of Health and Nutrition, Tokyo, 162-8636, Japan. ishimi@nih.go.jp
Y
Y
Ishimi
N
N
Arai
X
X
Wang
J
J
Wu
K
K
Umegaki
C
C
Miyaura
A
A
Takeda
S
S
Ikegami
D000818:Animals; D001842:Bone and Bones / Q000187:drug effects* / Q000473:pathology*; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005260:Female; D019833:Genistein / Q000008:administration & dosage* / Q000009:adverse effects; D007529:Isoflavones / Q000008:administration & dosage / Q000009:adverse effects; D051379:Mice; D010024:Osteoporosis / Q000517:prevention & control*; D010052:Ovariectomy; D013025:Glycine max; D014599:Uterus / Q000187:drug effects* / Q000473:pathology*
D004791:Enzyme Inhibitors; D007529:Isoflavones; D019833:Genistein